Flow Cytometric Immunophenotyping



Fig. 5.1
Multicolor flow cytometric immunophenotyping on fine-needle aspiration sample (example 1): the histogram shows coexpression of CD19 and CD5, an important feature of mantle cell lymphoma



A327462_1_En_5_Fig2_HTML.gif


Fig. 5.2
Multicolor flow cytometric immunophenotyping on fine-needle aspiration sample (example 2): the histogram shows monotypic B-cell population with lambda light chain restriction


In nonneoplastic conditions, the specimen comprises a mixture of T and B cells. In addition to CD19, CD20, and CD22, mature nonneoplastic B cells typically express polytypic surface immunoglobulin. B-cell lymphomas, however, express a single clonal light chain (also called light chain restriction ), so the kappa-to-lambda ratio is either substantially increased or decreased due to a significant lambda excess. Ki67 immunostaining on cytospin preparation (Fig. 4.​13) is often included in lymphoma workup to help tumor grading, to aid in the diagnosis of Burkitt lymphoma , or to confirm the blastoid nature of mantle cell lymphoma. The aberrant expression of some antigens in B-cell lymphomas may be of prognostic value. For example, CD38 expression in B-cell SLL/CLL is often associated with a more aggressive clinical course. Table 5.1 lists the key immunophenotypic and molecular features of mature B-cell neoplasms commonly encountered in cytology practice.


Table 5.1
Immunophenotypic and molecular features of mature B-cell neoplasms commonly encountered in cytology practice




























































Tumor type

Immunophenotype

Cytogenetic change

Burkitt/atypical Burkitt lymphoma

CD45+, sIg+, CD79a+, CD19+, CD20+, CD10+, BCL6+, high Ki67 index (nearly 100 %)

Most common: t(8;14)(q24;q32); less common: t(2;8)(p12;q24) or t(8;22)(q24;q11)

CD5−, CD23−

Follicular lymphoma

CD45+, sIg+, CD79a+, CD19+, CD20+, CD10+ (occasionally CD10−), BCL6+

Most common: t(14;18)(q32;q21); rarely: t(2;8)(p11;q21) and t(18;22)(q21;q11)

CD5−, CD23+/−

Large B-cell lymphoma

CD45+, sIg+, cIg+ or Ig undetectable, CD79a+, CD19+, CD20+, high Ki67 index

t(14;18)(q32;q21)

CD10−/+, BCL6−/+, CD5−/+

Lymphoplasmacytic lymphoma

CD45+, sIg+, cIg+, CD79a+, CD19+/−, CD20+/−, CD38+, CD43+/−
 

CD10−, CD5−, CD23−

Mantle cell lymphoma

CD45+, sIg+, CD79a+, CD19+, CD20+, CD5+, FMC7+, CD79a+, BCL1 (cyclin D1)+, SOX11+

t(11;14)(q13;q32)

CD10−, CD23−

Marginal zone lymphoma (splenic or nodal) and MALT lymphoma

CD45+, sIg+, CD79a+, CD19+, CD20+

t(11,18)(q21;q21), t(14;18)(q32;q21), t(3;14)(p14.1;q32), trisomy 3, and trisomy 18 (more common in MALT lymphoma)

CD10−, CD5−, CD23−, BCL6−

Plasma cell neoplasms

CD45+/−, cIg+, CD79a+, CD38+, CD138+, MUM1+, CD56+/−

t(11;14)(q13;q32)

CD19−, CD20−, sIg−

Small lymphocytic lymphoma/chronic lymphocytic leukemia

CD45+, dim sIg+, CD79a+, CD19+/−, dim CD20+, dim CD22+, CD5+, CD23+, (CD38+, and ZAP70+: worse prognosis)

Trisomy 12, 13q14 deletion, 17p and 11q deletions

CD10−, FMC7−


Abbreviations: MALT lymphoma mucosa-associated lymphoid tissue lymphoma, Ig immunoglobulin light chain, sIg surface Ig restriction, cIg cytoplasmic Ig restriction

Although in most cases, the interpretation of flow cytometric data is quite straightforward, traps may be encountered. Correlation of flow cytometric data with clinical and cytologic findings and Ki67 staining is important. In rare cases, cytogenetic or molecular studies may also be needed. Interpreting a case solely on the basis of flow cytometric results may lead to an erroneous diagnosis. Negative findings do not necessarily indicate a benign process.

Jul 8, 2017 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Flow Cytometric Immunophenotyping

Full access? Get Clinical Tree

Get Clinical Tree app for offline access